Life Science & Health Care
| Rank | Name | Agg. Deals Value | Clients Dimension | N. of Transactions |  |
 |
 |
 |
 |
Last Quarter |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Allen & Overy | 6065 | 1190 | 5 | 100% | 100% | 85% | 90% | 95% |  |
| 2 | Kirkland & Ellis | 4500 | 5000 | 1 | na | na | na | na | na | |
| 3 | Gowling WLG | 4065 | 3833 | 3 | 100% | 100% | 100% | 100% | 100% |  |
| 4 | Goodwin Procter | 1215 | 48 | 5 | na | na | na | na | na | |
| 5 | Ropes & Gray | 1000 | 1765 | 4 | na | na | na | na | na |  |
| 6 | McDermott Will & Emery | 995 | 163 | 2 | 100% | 100% | 100% | 95% | 100% | |
| 7 | Mills & Reeve LLP | 950 | 75 | 1 | na | na | na | na | na | |
| 8 | Travers Smith | 400 | 875 | 2 | na | na | na | na | na | |
| 9 | Linklaters | 350 | 25 | 1 | 100% | 100% | 100% | 100% | 100% | |
| 10 | Hill Dickinson | 290 | 86 | 7 | na | na | na | na | na | |
| 11 | Stephenson Harwood | 250 | 600 | 1 | na | na | na | na | na | |
| 12 | Pinsent Masons | 165 | 5000 | 3 | na | na | na | na | na | |
| 13 | Memery Crystal | 165 | 25 | 2 | 100% | 100% | 100% | 100% | 75% | |
| 14 | Osborne Clarke | 85 | 600 | 1 | 88% | 88% | 88% | 63% | 75% | |
| 15 | Browne Jacobson | 55 | 75 | 1 | na | na | na | na | na | |
| 16 | Sidley Austin LLP | 50 | 1788 | 2 | na | na | na | na | na | |
| 17 | Bird & Bird | 35 | 508 | 1 | 91% | 91% | 89% | 89% | 89% | |
| 18 | Charles Russell Speechlys | 30 | 75 | 2 | na | na | na | na | na | |
| 19 | DLA Piper | 25 | 25 | 1 | 93% | 100% | 100% | 96% | 96% | |
| 20 | Baker McKenzie | 5 | 5000 | 1 | 90% | 95% | 95% | 95% | 95% | |
| 21 | Taylor Wessing | 5 | 25 | 1 | na | na | na | na | na | |
| 22 | Bryan Cave Leighton Paisner | 1 | 250 | 1 | na | na | na | na | na | |
| Rank | Name | Agg. Deals Value | Clients Dimension | N. of Transactions | |
|
|
|
|
Last Quarter |